- $2.32bn
- $2.36bn
- $673.63m
- 53
- 67
- 72
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 498 | 496 | 497 | 541 | 497 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 482 | 381 | 548 | 548 | 488 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 286 | 189 | 326 | 291 | 227 |
Provision for Income Taxes | |||||
Net Income After Taxes | 226 | 154 | 253 | 226 | 171 |
Net Income Before Extraordinary Items | |||||
Net Income | 226 | 154 | 253 | 226 | 171 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 226 | 154 | 250 | 218 | 163 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.59 | 4.04 | 6.65 | 5.53 | 4.25 |
Dividends per Share |